Hepatocyte specific antigen/Hep-Par 1

OCH1E5, Ms, 6 ml RTU

Technische Daten
Reaktivität AK:Human, others not tested.
Format AK:Ready-to-use
Immunogen:Hepatocyte Specific Antigen
Anwendung AK:IHC(p),IHC(f)
Fixierung:1) NOTOXhisto 2) Formalin
Zelluläre Lokalisation:Cytoplasmic
Lagerung AK:Store at 2 - 8 °C. Do not use after expiration date indicated on the vial.
Ig Unterklasse:IgG1/k
Verfügbar in folgenden Ländern:world wide

Hepatocyte Specific Antigen is a monoclonal antibody considered almost specific for normal and neoplastic hepatocytes. It has been demonstrated consistently in the vast majority of hepatocellular carcinomas. This antibody recognizes both benign and malignant liver derived tissues including hepatoblastoma, hepatocellular carcinoma, and hepatic adenoma as well as normal adult and fetal liver tissue.


[1] Wang B, She J, Salio M et al. (1997): CD3-epsilon overexpressed in prothymocytes acts as an oncogene. Mol Med. 3(1):72-81.
[2] Termuhlen AM (2017): Natural killer/T-cell lymphomas in pediatric and adolescent patients. Clin Adv Hematol Oncol. 15(3):200-209.
[3] Li Y, Chen S, Yang L et al. (2011): Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. Hematology. 16(3):143-50.
[4] Chen S, Zha X, Yang L et al. (2011): Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients. Hematology. 16(1):31-6.
[5] Huang L, Chen S, Zha X et al. (2012): Expression feature of CD3, Fc_RI_, and Zap-70 in patients with chronic lymphocytic leukemia. Hematology. 17(2):71-5.
[6] Mason DY, Cordell J, Brown M et al. (1989): Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol. 42(11):1194-200.
[7] Sommers CL, Dejarnette JB, Huang KJ et al. (2000): Function of CD3 epsilon-mediated signals in T cell development. Exp Med. 192(6):913-19.
[8] Vilches-Moure JG and Ramos-Vara JA (2005): Comparison of rabbit monoclonal and mouse monoclonal antibodies in immunohistochemistry in canine tissues. J Vet Diagn Invest. 17(4):346-50.
[9] Oettgen HC, Kappler J, Tax WJ and Terhorst C (1984): Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes. J Biol Chem. 259(19):12039-48.
[10] Ziegler S, Weiss E, Schmitt AL et al. (2017): CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells. Sci Rep. 7:6138.
[11] Hu B and Oki Y (2018): Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma. Front Oncol. 8:139.